There are also non-genetic, interventional models based on intracranial stereotactic injections of synthetic Aβ aggregates, tau-enriched AD brain lysates, and, most commonly, streptozotocin (STZ) [142]. The gene discussed is MAPT; the disease is Alzheimer disease.